These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 35197452)

  • 21. Viral Coagulopathy in Patients With COVID-19: Treatment and Care.
    Kipshidze N; Dangas G; White CJ; Kipshidze N; Siddiqui F; Lattimer CR; Carter CA; Fareed J
    Clin Appl Thromb Hemost; 2020; 26():1076029620936776. PubMed ID: 32687449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Molecular Basis of COVID-19 Pathogenesis, Conventional and Nanomedicine Therapy.
    Kouhpayeh S; Shariati L; Boshtam M; Rahimmanesh I; Mirian M; Esmaeili Y; Najaflu M; Khanahmad N; Zeinalian M; Trovato M; Tay FR; Khanahmad H; Makvandi P
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34064039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promising drug repurposing approach targeted for cytokine storm implicated in SARS-CoV-2 complications.
    Shawki MA; Elsayed NS; Mantawy EM; Said RS
    Immunopharmacol Immunotoxicol; 2021 Aug; 43(4):395-409. PubMed ID: 34057871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cytokine storm and COVID-19.
    Hu B; Huang S; Yin L
    J Med Virol; 2021 Jan; 93(1):250-256. PubMed ID: 32592501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of anticoagulant therapy on the course of COVID-19 in comorbid patients].
    Ruzhentsova TA; Khavkina DA; Chukhliaev PV; Garbuzov AA; Ploskireva AA
    Vopr Virusol; 2021 Mar; 66(1):40-46. PubMed ID: 33683064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thromboembolic events and apparent heparin resistance in patients infected with SARS-CoV-2.
    Beun R; Kusadasi N; Sikma M; Westerink J; Huisman A
    Int J Lab Hematol; 2020 Jun; 42 Suppl 1(Suppl 1):19-20. PubMed ID: 32311843
    [No Abstract]   [Full Text] [Related]  

  • 27. A proof of evidence supporting abnormal immunothrombosis in severe COVID-19: naked megakaryocyte nuclei increase in the bone marrow and lungs of critically ill patients.
    Roncati L; Ligabue G; Nasillo V; Lusenti B; Gennari W; Fabbiani L; Malagoli C; Gallo G; Giovanella S; Lupi M; Salviato T; Paolini A; Costantini M; Trenti T; Maiorana A
    Platelets; 2020 Nov; 31(8):1085-1089. PubMed ID: 32857624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding the andromeda strain - The role of cytokine release, coagulopathy and antithrombin III in SARS-CoV2 critical illness.
    Mir N; D'Amico A; Dasher J; Tolwani A; Valentine V
    Blood Rev; 2021 Jan; 45():100731. PubMed ID: 32829961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proinflammatory cytokines are associated with prolonged viral RNA shedding in COVID-19 patients.
    Gao C; Zhu L; Jin CC; Tong YX; Xiao AT; Zhang S
    Clin Immunol; 2020 Dec; 221():108611. PubMed ID: 33068796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulmonary Embolism and Increased Levels of d-Dimer in Patients with Coronavirus Disease.
    Griffin DO; Jensen A; Khan M; Chin J; Chin K; Saad J; Parnell R; Awwad C; Patel D
    Emerg Infect Dis; 2020 Aug; 26(8):1941-1943. PubMed ID: 32348233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A unique tale of COVID-19 induced concomitant overt disseminated intravascular coagulation and acute bilateral pulmonary embolism.
    Siddiqui SN; Jayasekhar R; Tshering S; Jugjali R; Shanmugavadivel D; Jawed A; Rahman MM
    Int J Infect Dis; 2021 Mar; 104():568-571. PubMed ID: 33486013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sepsis-associated severe interleukin-6 storm in critical coronavirus disease 2019.
    Huang L; Zhao X; Qi Y; Li H; Ye G; Liu Y; Zhang Y; Gou J
    Cell Mol Immunol; 2020 Oct; 17(10):1092-1094. PubMed ID: 32917983
    [No Abstract]   [Full Text] [Related]  

  • 34. Hematologic disorders associated with COVID-19: a review.
    Rahi MS; Jindal V; Reyes SP; Gunasekaran K; Gupta R; Jaiyesimi I
    Ann Hematol; 2021 Feb; 100(2):309-320. PubMed ID: 33415422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombosis in COVID-19.
    Hanff TC; Mohareb AM; Giri J; Cohen JB; Chirinos JA
    Am J Hematol; 2020 Dec; 95(12):1578-1589. PubMed ID: 32857878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Innate immunity in COVID-19: Drivers of pathogenesis and potential therapeutic targets.
    Ruenjaiman V; Hirankarn N; Palaga T
    Asian Pac J Allergy Immunol; 2021 Jun; 39(2):69-77. PubMed ID: 34174806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogenesis guided therapeutic management of COVID-19: an immunological perspective.
    Kumar A; Prasoon P; Sekhawat PS; Pareek V; Faiq MA; Kumari C; Narayan RK; Kulandhasamy M; Kant K
    Int Rev Immunol; 2021; 40(1-2):54-71. PubMed ID: 33111578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role and delicate balance of Host Immunity in Coronavirus Disease-19.
    Vyas AK; Varma V; Garg G; Gupta P; Trehanpati N
    Iran J Immunol; 2021 Mar; 18(1):1-12. PubMed ID: 33787510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of vascular surgeons in the treatment of COVID-19-associated pulmonary embolism.
    Patelis N; Bisdas T; Tsiachris D; Stefanadis CI
    J Vasc Surg; 2020 Sep; 72(3):1148. PubMed ID: 32497750
    [No Abstract]   [Full Text] [Related]  

  • 40. Coronavirus Disease-2019 Treatment Strategies Targeting Interleukin-6 Signaling and Herbal Medicine.
    Dzobo K; Chiririwa H; Dandara C; Dzobo W
    OMICS; 2021 Jan; 25(1):13-22. PubMed ID: 32857671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.